Key Findings:  This reviewer suggests that using cannabis might benefit motor and non-motor aspects of Parkinson’s disease patients. However, he also points out that research has yet to produce a complex risk vs benefit analysis to offer practical advice to patients and their providers alike.
Type of Study:  Meta-analysis
Study Result:  Positive
Study Location(s):  United States
Year of Pub:  2019
Cannabinoids Studied:  Cannabidiol (CBD), Tetrahydrocannabinol (THC)
Phytocannabinoid Source:  Not Applicable
Receptors Studied:  CB1